Phio Pharmaceuticals Corp.
PHIO
$1.09
-$0.03-2.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.43% | -22.44% | -8.79% | -6.69% | 17.44% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -100.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 121.57% | 18.60% | 10.26% | -25.00% | 246.67% |
| Change in Net Operating Assets | 145.18% | -194.24% | 108.80% | 144.91% | -1,007.55% |
| Cash from Operations | 17.91% | -99.22% | 7.00% | 29.80% | -9.90% |
| Capital Expenditure | -133.33% | -50.00% | -100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -133.33% | -50.00% | -125.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5,030.00% | -99.56% | 576.47% | -48.75% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,955.00% | -99.56% | 576.97% | -48.77% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.20% | -131.70% | 98,800.00% | -101.16% | 138.94% |